Maxcell Bioscience, Inc. v. United States

533 F. Supp. 2d 1261, 31 Ct. Int'l Trade 1999, 31 C.I.T. 1999, 30 I.T.R.D. (BNA) 1179, 2007 Ct. Intl. Trade LEXIS 182
CourtUnited States Court of International Trade
DecidedDecember 18, 2007
DocketSlip Op. 07-180; Court 04-00254
StatusPublished

This text of 533 F. Supp. 2d 1261 (Maxcell Bioscience, Inc. v. United States) is published on Counsel Stack Legal Research, covering United States Court of International Trade primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Maxcell Bioscience, Inc. v. United States, 533 F. Supp. 2d 1261, 31 Ct. Int'l Trade 1999, 31 C.I.T. 1999, 30 I.T.R.D. (BNA) 1179, 2007 Ct. Intl. Trade LEXIS 182 (cit 2007).

Opinion

OPINION

RIDGWAY, Judge.

At issue in this action is the tariff classification of MetaBérry and Aloe Gold, two liquid “dietary supplements” imported from Korea by plaintiff MaxCell BioSci-ences, Inc. in 2002 and 2003.

*1262 The Bureau of Customs and Border Protection 1 liquidated the subject entries of the two products under subheading 2106.90.99 of the Harmonized Tariff Schedule of the United States (“HTSUS”). 2 That subheading covers “[f]ood preparations not elsewhere specified or included,” which are dutiable at the rate of 6.4% ad valorem. MaxCell claims that the merchandise is instead classifiable as “other nonalcoholic beverages” under subheading 2202.90.90, subject to duties at the rate of 0.2.t per liter.

Cross-motions for summary judgment are pending. See generally Plaintiffs Memorandum of Law in Support of Its Motion for Summary Judgment (“Pl.’s Brief’); Plaintiffs Memorandum of Law in Opposition to Defendant’s Cross Motion for Summary Judgment (“Pl.’s Reply Brief’); Defendant’s Memorandum in Opposition to Plaintiffs Motion for Summary Judgment and in Support of Defendant’s Cross-Motion for Summary Judgment (“Def.’s Brief’); Defendant’s Reply Memorandum in Opposition to Plaintiffs Motion for Summary Judgment and in Support of Defendant’s Cross-Motion for Summary Judgment (“Def.’s Reply Brief’).

Jurisdiction lies under 28 U.S.C. § 1581(a) (2000). 3 Customs’ classification decisions are subject to de novo review pursuant to 28 U.S.C. § 2640.

For the reasons set forth below, Meta-Berry and Aloe Gold are properly classified as “[flood preparations not elsewhere specified or included,” under subheading 2106.90.99 of the HTSUS. MaxCell’s motion for summary judgment is therefore denied, and the Government’s cross-motion is granted. 4

I. The Merchandise at Issue

The two products at issue in this matter — MetaBerry and Aloe Gold — are liquid “dietary supplements,” sold in wide-mouth, 32 fluid ounce plastic containers. 5 The *1263 labels on both products indicate that there are 32 servings per container. And the instructions for suggested use indicate that MetaBerry and Aloe Gold are to be taken in measured, one- to two-ounce doses before each meal, “or as needed.” To that end, the cone-shaped cap that tops each of the products is designed to serve as a measuring cup, with lines marked on the interior of the cap to indicate specific dosages (including one and two ounces). 6

Maxcell markets MetaBerry as a substance which optimizes oxygen and glucose delivery to the brain, protects the body from free radicals, enhances the immune system, and fosters cardiovascular and urinary tract health. The label on the container prominently touts MetaBerry as an “ANTI-CATABOLIC,” a “Dietary Supplement,” and a “Mind Body Formula & High Potency Antioxidant.” 7 Similarly, Aloe Gold is marketed as a substance which slows the aging process by decreasing ca-tabolic activity through increased antioxidant activity, and which restores the body’s ideal pH, restores water balance in the colon, and supports the natural healing and renewing mechanisms of the gastrointestinal tract. Like MetaBerry, Aloe Gold is also labeled as an “ANTICATABOLIC” and a “Dietary Supplement.”

According to the list of ingredients on the label, MetaBerry is a preparation based on a “Fruit Blend (concentrate)” of blueberry, cranberry, cherry, and grape, together with aloe vera, ginkgo biloba, alpha lipoic acid, as well as a proprietary herbal blend of jujube extract, black pepper, active aloe, and Chinese licorice, plus preservatives. 8 The product has a somewhat bitter, medicinal taste. And a warning on the label cautions against use by pregnant or nursing women without consulting a physician.

The list of ingredients on the Aloe Gold label indicates that it is a preparation consisting of active aloe, carragel, 9 pine needle extract, citric acid, and green tea extract, as well as the same proprietary herbal blend and preservatives that MetaBerry contains. 10 Aloe Gold has an oily appearance, and a texture or consistency similar to that of cod liver oil. And, like MetaBer-ry, Aloe Gold too is labeled to warn against *1264 its use by pregnant or nursing women without consulting a physician.

MetaBerry and Aloe Gold are sold through two main channels. Both products are offered for sale though the website of MaxCell’s distributor, Oasis LifeSei-ences, alongside other products advertised as “part of a healthy and nutritious lifestyle which brings back the hope and vitality of youth.” In addition, the two products are available for purchase through agents known as “independent Associates,” who host “Ageless Living” events in their homes to promote Metaberry and Aloe-Gold, along with other Oasis LifeSciences products. A 32 fluid ounce container of MetaBerry costs approximately $38.25, while a container of Aloe Gold sells for approximately $25.95 — roughly $1.20 per ounce and $0.80 per ounce, respectively.

Customs’ position concerning the classification of MetaBerry and Aloe Gold is set forth in Headquarters ruling letters HQ 966849 and HQ 966850, respectively. See HQ 966849 (April 26, 2004); HQ 966850 (April 27, 2004). 11

II. Standard of Review

Pursuant to USCIT Rule 56, summary judgment is appropriate where “there is no genuine issue as to any material fact and ... the moving party is entitled to ... judgment as a matter of law.” USCIT R. 56(c).

Customs’ classification determinations are reviewed through a two-step process. First, the relevant tariff headings must be construed,' which is a question of law. And, second, a determination must be made as to the tariff term under which the merchandise at issue falls, which is a question of fact. Bausch & Bomb, Inc. v. United States, 148 F.3d 1363, 1364-65 (Fed.Cir.1998) (citation omitted). Thus, in customs classification cases, “summary judgment is appropriate when there is no genuine dispute as to the underlying factual issue of exactly what the merchandise is.” Bausch & Bomb, 148 F.3d at 1365 (citations omitted).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Skidmore v. Swift & Co.
323 U.S. 134 (Supreme Court, 1944)
United States v. Mead Corp.
533 U.S. 218 (Supreme Court, 2001)
Warner-Lambert Co. v. United States
407 F.3d 1207 (Federal Circuit, 2005)
Mita Copystar America v. United States
21 F.3d 1079 (Federal Circuit, 1994)
Bausch & Lomb, Incorporated v. United States
148 F.3d 1363 (Federal Circuit, 1998)
Primal Lite, Inc. v. United States
182 F.3d 1362 (Federal Circuit, 1999)
North American Processing Company v. United States
236 F.3d 695 (Federal Circuit, 2001)
Rollerblade, Inc. v. United States
282 F.3d 1349 (Federal Circuit, 2002)
Structural Industries, Inc. v. United States
356 F.3d 1366 (Federal Circuit, 2004)
Basf Corporation v. United States, Defendant-Cross
482 F.3d 1324 (Federal Circuit, 2007)
Inabata Specialty Chemicals v. United States
366 F. Supp. 2d 1358 (Court of International Trade, 2005)
Cosmos International v. United States
760 F. Supp. 914 (Court of International Trade, 1991)
Strohmeyer v. United States
28 C.C.P.A. 34 (Customs and Patent Appeals, 1940)
United States v. Carborundum Co.
536 F.2d 373 (Customs and Patent Appeals, 1976)

Cite This Page — Counsel Stack

Bluebook (online)
533 F. Supp. 2d 1261, 31 Ct. Int'l Trade 1999, 31 C.I.T. 1999, 30 I.T.R.D. (BNA) 1179, 2007 Ct. Intl. Trade LEXIS 182, Counsel Stack Legal Research, https://law.counselstack.com/opinion/maxcell-bioscience-inc-v-united-states-cit-2007.